Clinical Trial

Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)

Study acronym: UNIQUE
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to retrospectively and prospectively collect clinical and biological specimen data from patients with cardiac tumors who meet the inclusion and exclusion criteria. Various techniques, including general molecular biology analysis and multi-omics analysis, will be used to construct a prognostic model for cardiac tumors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-19; most recent amendment 2024-07-10.
Status change: Not Yet Recruiting → Recruiting 2024-07-10
Trial Details
NCT Number NCT06100328
Lead Sponsor First Affiliated Hospital Xi'an Jiaotong University
Conditions Cardiac Tumor
Enrollment 40 participants
Start Date 2023-10-26
Primary Completion 2030-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-12